Ding Wang
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 42
- Cancer Immunotherapy and Biomarkers 21
- Colorectal Cancer Treatments and Studies 7
- Lung Cancer Research Studies 6
- Co-authors
- James L. Gulley (13 shared papers)Manish R. Patel (14 shared papers)Jeffrey R. Infante (11 shared papers)Alain Ravaud (8 shared papers)Andrea B. Apolo (8 shared papers)Carolyn D. Britten (7 shared papers)Karen Kelly (14 shared papers)Arnold B. Gelb (4 shared papers)
- Journals
- Journal of Clinical Oncology (29 papers)Blood (4 papers)Journal for ImmunoTherapy of Cancer (3 papers)Medicine (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Ding Wang
127 papers receiving 3.7k citations
Ding Wang's Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 1.5k
- Immunology 834
- Genetics 263
- Surgery 848
- Cancer Research 247
Countries citing papers authored by Ding Wang
This map shows the geographic impact of Ding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Wang more than expected).
Fields of papers citing papers by Ding Wang
This network shows the impact of papers produced by Ding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Wang. The network helps show where Ding Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 477 |
| 2 | Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Hit paper breakdown → | 2017 | 442 |
| 3 | 2014 | 314 | |
| 4 | 2017 | 229 | |
| 5 | 2010 | 167 | |
| 6 | 2009 | 162 | |
| 7 | 2006 | 157 | |
| 8 | 2015 | 74 | |
| 9 | 2019 | 68 | |
| 10 | 2020 | 65 | |
| 11 | 2020 | 63 | |
| 12 | 2006 | 58 | |
| 13 | 2015 | 58 | |
| 14 | 2005 | 51 | |
| 15 | 2014 | 50 | |
| 16 | 2006 | 50 | |
| 17 | 2013 | 47 | |
| 18 | 2019 | 46 | |
| 19 | 2015 | 42 | |
| 20 | 2022 | 42 |
About Ding Wang
Ding Wang is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 135 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Bladder and Urothelial Cancer Treatments (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Urinary and Genital Oncology Studies (6 papers), MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (6 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (834 citations), Genetics (263 citations), Surgery (848 citations) and Cancer Research (247 citations). Ding Wang has collaborated with scholars based in United States, China and France. Frequent co-authors include James L. Gulley, Manish R. Patel, Jeffrey R. Infante, Alain Ravaud, Andrea B. Apolo, Carolyn D. Britten, Karen Kelly, Arnold B. Gelb, Kevin M. Chin and Anthony Mega. Their work appears in journals such as Journal of Clinical Oncology, Blood, Journal for ImmunoTherapy of Cancer, Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.